Discovered in 1926 and developed in the 1930s-1950s, it was demonstrated repeatedly at US academic and military hospitals. Despite 70 years of consistent efforts by IPT doctors to publicize their remarkable successes and teach their technique, IPT has never been widely adopted, and laboratory research and clinical trials have never been carried out. Most likely this is because the technique is significantly different from existing procedures, and because sharp dose reduction does not fit into the standard pharmaceutical company business model. Health care costs are out of control, and there is increasing openness to procedures which can reduce costs and improve outcomes. Government and health care providers, more than the pharma companies, are now determining the agenda.
Medicine now competes directly with alternative therapies.
It would be to the advantage of MDs to offer a treatment that is more effective, safer, and nontoxic. A revival of interest in IPT research and implementation will create an opportunity to develop medical devices and drug packaging systems that support the procedure. And the discoverer of IPT developed, decades ago, a simple colorimetric electrochemical blood analysis system that deserves investigation, and possible improvement with the optics and electronics of today. Deliver information about IPT to key doctors and departments at Stanford Medical Center and School of Medicine, as well as at UCSF and around the Bay Area. Stimulate collaborative laboratory research and clinical trials with IPT in several medical departments, by offering the challenge, by attracting funds, and by fostering a community of IPT researchers.